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Multiple colonization with highly resistant bacteria: carbapenemase-
producing Enterobacteriaceae, carbapenemase-producing Pseudomonas
aeruginosa, carbapenemase-producing Acinetobacter baumannii, and
glycopeptide-resistant Enterococcus faecium
To the Editors,
The dissemination of carbapenemase-producing bacteria worldwide
is an important source of concern because carbapenemase producers
are multidrug resistant (Nordmann and Poirel, 2014). National guide-
lines increasingly recommend a systematic screening of at least
carbapenemase-producing Enterobacteriaceae (CPE) and glycopeptide-
resistant enterococci (GRE) in patients admitted to hospitals who have
been hospitalized aboard during the preceding 12 months (Lepelletier
et al., 2011).We have investigated the occurrence of colonization and in-
fection with multiple highly resistant bacteria of more than 4 different
genus in 2 patients directly transferred from a foreign country.
In June 2014, a 33-year-old Frenchman (patient A)was admitted for a
suicide attempt in a Vietnamese hospital where he was treated during
10 days for pneumonia with piperacillin + tazobactam before his trans-
fer to Necker-Enfants Malades University Hospital in Paris, France. At
the day of his hospitalization in France, distal protected pulmonary
samples were collected, and imipenem was administered subsequently
to a persistent fever. In addition, systematic screening to detect
carbapenemase producers and GRE was also performed. Screening of
extended spectrum β-lactamase (ESBL) producing Enterobacteriaceae,
carbapenemase producers, and GRE was done on selective media
(bioMérieux, La Balme-les-Grottes, France) ChromID ESBL, ChromID
Carba Smart, and VRE medium, respectively. Carbapenemase production
was identiﬁed using the Carba NP test for Enterobacteriaceae (Dortet
et al., 2014a) and Pseudomonas aeruginosa (Dortet et al., 2012) and
CarbAcineto NP test for Acinetobacter baumannii (Dortet et al., 2014b).
Deﬁnitive identiﬁcations of resistance determinant were done by PCR
ampliﬁcations followed by sequencing. Pulmonary samples grew an
OXA-23–producing A. baumannii isolate and an IMP-1–producing P.
aeruginosa (Table 1). Screening identiﬁed also that the patient was
colonized with a KPC-2–producing Klebsiella pneumoniae, a CTX-M-15–
producing K. pneumoniae, and a VanA-positive glycopeptide-resistant En-
terococcus faecium (Table 1).
Patient B was a 66-year-old French womanwhowas hospitalized in
May 2014 in the intensive care unit of Paris suburb (Saint-Denis,
France). She was directly transferred from Morocco, where she was
admitted in the intensive care unit consecutively to a road accident.
Seven days after her admission, she developed a ventilation-associated
pulmonary infection due to a multidrug-resistant P. aeruginosa that
was treated with imipenem, colistin, metronidazole, and ﬂuconazole
for 14 days. Twenty-one days after the admission, the patient developed
another pulmonary infection due to a multidrug-resistant A. baumannii
only susceptible to colistin, resulting in her transfer to the French
hospital. At the admission, the systematic screening of CPE using rectal
swab samples revealed the presence of an OXA-48–producing K.
pneumoniae (Table 1). After 24 hours, the patient developed a pyelone-
phritis due to a VIM-4–producing P. aeruginosa and a bronchitis due to
an OXA-23–producing A. baumannii (Table 1), which were treated
with amikacin, fosfomycin, and colistin. Although apyrexia was
Table 1
Clinical data on the 2 patients hospitalized in France after hospitalization in another country and were carrying multidrug-resistant bacteria.
Patient Country of initial hospitalization Species Clinical sample β-Lactamase contenta Non–β-lactam resistance determinants
A Vietnam A. baumannii PDP OXA-23 ArmA
P. aeruginosa PDP IMP-1
K. pneumoniae Rectal swab KPC-2, CTX-M-15, TEM-1, SHV-1, OXA-1 AAC6′-Ib-cr, QnrB
K. pneumoniae Rectal swab CTX-M-15, TEM-1, SHV-1, OXA-1 AAC6′-Ib-cr, QnrB
E. faecium Rectal swab None VanA
B Morocco A. baumannii PDP OXA-23
P. aeruginosa Urine and blood culture VIM-4
P. rettgeri Urine NDM-1, CTX-M-15, SHV-12, TEM-1, AAC6′-Ib-cr, QnrB
K. pneumoniae Rectal swab OXA-48, CTX-M-15, OXA-9 AAC6′-Ib-cr, QnrB
PDP = distal protected pulmonary sample.














obtained in 3 days, fever reappeared under colistin treatment. A natural-
ly colistin-resistant Providentia rettgeri isolate producing the NDM-1
carbapenemase was isolated from 3 successive urine samples recov-
ered by urinary catheter (Table 1). The urinary catheter was re-
moved, and the patient received 2 doses of amikacin, leading to a
rapid apyrexia.
Co-occurrence of multiple resistance determinants in the
same species has become a common feature among carbapenemase pro-
ducers (Compain et al., 2014). Nevertheless, co-occurrence in the same
patient of a least 4 different highly resistant bacterial species is worri-
some because it might potentially lead to a real therapeutic deadlock.
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